HOME FOREIGN MARKETS AWARDS PRESS QUESTIONNAIRES CONTACT SITEMAP TR EN
ABOUT BILIM PRODUCTS R&D CORPORATE RESPONSIBILITY PRODUCTION PLANTS CAREER
CEO'S MESSAGE
BILIM PHARMACEUTICALS AND CORPORATE RESPONSIBILITY
SUSTAINABILITY MANAGEMENT
ECOLOGICAL SENSITIVITY
SOCIAL SENSITIVITY
OUR WORK AND LABOR PRACTICES AND EMPLOYEE RIGHTS
OUR PRINCIPLES ON EMPLOYEE RIGHTS
MANAGEMENT OF DIFFERENCES
OCCUPATIONAL HEALTH AND SAFETY
PRODUCT RESPONSIBILITY
MARKETING PRINCIPLES AND ETHICS
OUR SUPPLIERS - COLLABORATIONS
INVESTMENT IN THE COMMUNITY
ECONOMIC ADDED VALUE
CORPORATE RESPONSIBILITY REPORTS
PRODUCT RESPONSIBILITY
Patient safety is one of our most primary issues within the framework of our sustainability policy.

Due to the nature of the sector we serve, our establishment operates in compliance with cGMP (current Good Manufacturing Practices) quality management standards, an issue which is set forth in legislations as per regulations. GMP regulations and the quality system are not confined to the production processes, but apply to all processes from purchase to delivery, which affect product and production quality.

Following the certification process, we evaluate to what extent our products, which we offer to the use of our consumers, are effective and reliable and whether they are easy-to-apply; we pay attention to the feedback we receive and effect improvements where necessary. We keep close view of publications and evaluations that include scientific developments regarding our products and try to provide patients/users, health care providers and public authorities with up-to-date and qualified information on risks and benefits of our products.

We do not limit the safety profile of our products to the pre-certification period; our monitoring continues even after we release these products to the market and we continue to perform necessary improvement, development and notifications. We try to collect as much information as possible about our products. For this purpose, we have commissioned “medical sales representatives”, whom our stakeholders -primarily patients and health professionals- can reach in the first plan, as well as assistants, safety and call centre employees. This way, as Bilim Pharmaceuticals, we inform our employees through our specialized instructors about what they have to do when they receive feedback concerning the safety, quality or performance of our products. In line with our policies, as well as the law and regulations, we monitor all feedback related to the quality, safety and effectiveness of our products and notify respective authorities where necessary.

We respond to feedback concerning product quality by performing required analysis and evaluations, responding immediately and effect improvements after obtaining legally required permits.
    
We continuously carry out development efforts in order to raise the level of safety and quality of our products.
CORPORATE RESPONSIBILITY REPORTS
Corporate Responsibility Reports
We share our responsibility...
CREATIVE IDEA PLATFORM
Creative Idea Platform
We attach importance to creative ideas!
Click to share yours....
COMMUNITY VOLUNTEERS
Community Volunteers
To be a part of the solution!
Bilim Community Volunteers...
EFQM EXCELLENCE AWARD
Alzheimer's Call Centre
2011 EFQM Excellence Award Winner is Bilim İlaç
CareerCareer SitemapSitemap Contact UsContact Us
Contact FormContact Form News from BilimNews from Bilim PressPress
QuestionnairesQuestionnaires Big ViewBig View RSSRSS
Please sign up to be notified about news from Bilim Pharmaceuticals
Follow us! Facebook Twitter Linkedin
© 2005-2017 Bilim Pharmaceuticals
BILIM PLAZA Piyalepasa Bulvari Kaptanpasa Mah. Zincirlikuyu Cad. No:184 34440 Beyoglu - Istanbul
Phone: +90 (212) 365 15 00 - Fax: +90 (212) 276 29 19
Information on this site, does not substitute for consulting your doctor or pharmacist.